FDA Inspection 1220163 — Massachusetts General Hospital Fertility Center

Massachusetts General Hospital Fertility Center — FEI 3003927046

The FDA completed an inspection of Massachusetts General Hospital Fertility Center on September 21, 2023 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 21, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Boston, MA (United States)